Cadrenal Therapeutics, Inc. (CVKD) Tops Q1 EPS by 31c

Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q1 EPS of ($1.04), $0.31 better than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Honda and Nissan to jointly develop vehicle sofware, Nikkei reports
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79